Via Nova Therapeutics

Oakland, United States

Via Nova Therapeutics is to discover and develop therapeutics for acute and subacute viral infections.

$5.0M raised

Sep 2021

Venture - Series Unknown

Biotechnology Life Science Therapeutics

Top Investors

Aditum Bio

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Via Nova Therapeutics

How much funding has Via Nova Therapeutics raised?

Via Nova Therapeutics has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2021.

Who are Via Nova Therapeutics's investors?

Via Nova Therapeutics's investors include Aditum Bio.

Where is Via Nova Therapeutics headquartered?

Via Nova Therapeutics is headquartered in Oakland, United States.

What does Via Nova Therapeutics do?

Via Nova Therapeutics is to discover and develop therapeutics for acute and subacute viral infections.

What stage is Via Nova Therapeutics at?

Via Nova Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 15, 2021.

MLA

"Via Nova Therapeutics — Funding & Investors." VCBacked, September 15, 2021, https://www.vcbacked.co/company/via-nova-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2021). Via Nova Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/via-nova-therapeutics

Wikipedia (cite web)

{{cite web |title=Via Nova Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/via-nova-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 15, 2021.